Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
N Engl J Med. 2022 Jun 5. doi: 10.1056/NEJMoa2203690. Online ahead of print.
N Engl J Med. 2022.
PMID: 35665782